Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Emilio Itarte"'
Autor:
Estefania Alcaraz, Jordi Vilardell, Christian Borgo, Eduard Sarró, Maria Plana, Oriano Marin, Lorenzo A Pinna, José R Bayascas, Anna Meseguer, Mauro Salvi, Emilio Itarte, Maria Ruzzene
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0227340 (2020)
The PI3K/Akt pathway is interconnected to protein kinase CK2, which directly phosphorylates Akt1 at S129. We have previously found that, in HK-2 renal cells, downregulation of the CK2 regulatory subunit β (shCK2β cells) reduces S129 Akt phosphoryla
Externí odkaz:
https://doaj.org/article/69543d1d78a64740811782633ddbd0bf
Autor:
Laura Ferrer-Font, Lucia Villamañan, Nuria Arias-Ramos, Jordi Vilardell, Maria Plana, Maria Ruzzene, Lorenzo A. Pinna, Emilio Itarte, Carles Arús, Ana Paula Candiota
Publikováno v:
Pharmaceuticals, Vol 10, Iss 1, p 24 (2017)
Glioblastoma (GBM) causes poor survival in patients even with aggressive treatment. Temozolomide (TMZ) is the standard chemotherapeutic choice for GBM treatment but resistance always ensues. Protein kinase CK2 (CK2) contributes to tumour development
Externí odkaz:
https://doaj.org/article/e670bbaecb9a42958d9d85d51579d85e
Autor:
Olga Tornavaca, Eduard Sarró, Gloria Pascual, Beatriz Bardaji, M Angeles Montero, M Teresa Salcedo, Maria Plana, Joan López-Hellin, Emilio Itarte, Anna Meseguer
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e25746 (2011)
The use of cyclosporine A (CsA) is limited by its severe nephrotoxicity that includes reversible vasoconstrictor effects and proximal tubule cell injury, the latter associated whith chronic kidney disease progression. The mechanisms of CsA-induced tu
Externí odkaz:
https://doaj.org/article/ba9429455e464ae4a4261e9e29aa6d92
Autor:
Anna Meseguer, Juan Morote, Emilio Itarte, Santiago Ramón y Cajal, Alex Sánchez, Joan López-Hellin, Mayte Salcedo, Inés de Torres, Jordi Vilardell, Maya R. Vilà, Eduard Sarró, Enric Trilla, Thaïs Cuadros
PDF file - 116K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbc00984a38257bd88b7764ed0bfcb67
https://doi.org/10.1158/0008-5472.22400580
https://doi.org/10.1158/0008-5472.22400580
Autor:
Anna Meseguer, Juan Morote, Emilio Itarte, Santiago Ramón y Cajal, Alex Sánchez, Joan López-Hellin, Mayte Salcedo, Inés de Torres, Jordi Vilardell, Maya R. Vilà, Eduard Sarró, Enric Trilla, Thaïs Cuadros
Renal cell carcinoma (RCC), the third most prevalent urological cancer, claims more than 100,000 lives/year worldwide. The clear cell variant (ccRCC) is the most common and aggressive subtype of this disease. While commonly asymptomatic, more than 30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::383c407ba80aed6fe7bdf8498c1d441f
https://doi.org/10.1158/0008-5472.c.6505623
https://doi.org/10.1158/0008-5472.c.6505623
Autor:
Anna Meseguer, Juan Morote, Emilio Itarte, Santiago Ramón y Cajal, Alex Sánchez, Joan López-Hellin, Mayte Salcedo, Inés de Torres, Jordi Vilardell, Maya R. Vilà, Eduard Sarró, Enric Trilla, Thaïs Cuadros
PDF file - 701K, Figure S1. RT-qPCR performed in independent clones confirmed that HAVCR/KIM-1 overexpressing 769-P cells exhibited increased mRNA IL-6 levels. Figure S2. As for 769-P cells, HAVCR/KIM-1 overexpression in 786-O cells (FUW-HAVCR) corre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2725bf56b96925ccdaa2c7307148865
https://doi.org/10.1158/0008-5472.22400583.v1
https://doi.org/10.1158/0008-5472.22400583.v1
Autor:
Maria Ruzzene, Emilio Itarte, Lucia Villamañan, Ana Paula Candiota, Lorenzo A. Pinna, Maria Plana, Estefania Alcaraz, Carles Arús
Publikováno v:
Pathology & Oncology Research. 25:1659-1663
Glioblastoma (GB) is the most prevalent malignant primary brain tumor in adults. The preclinical glioblastoma model GL261 is widely used for investigating new therapeutic strategies. GL261 cultured cells are used for assessing preliminary in vitro da
Autor:
Christian Borgo, Lorenzo A. Pinna, Jose R. Bayascas, Mauro Salvi, Maria Ruzzene, Anna Meseguer, Emilio Itarte, Maria Plana, Oriano Marin, Jordi Vilardell, Eduard Sarró, Estefania Alcaraz
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
PLoS ONE, Vol 15, Iss 1, p e0227340 (2020)
PLoS ONE
Universitat Autònoma de Barcelona
PLoS ONE, Vol 15, Iss 1, p e0227340 (2020)
PLoS ONE
The PI3K/Akt pathway is interconnected to protein kinase CK2, which directly phosphorylates Akt1 at S129. We have previously found that, in HK-2 renal cells, downregulation of the CK2 regulatory subunit β (shCK2β cells) reduces S129 Akt phosphoryla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5627839cc3c2fab6d52958560ab7df56
https://ddd.uab.cat/record/226171
https://ddd.uab.cat/record/226171
Autor:
Juan Morote, Jordi Vilardell, Enric Trilla, Santiago Ramón y Cajal, Anna Meseguer, Inés de Torres, Estefania Alcaraz, Maria Ruzzene, Lorenzo A. Pinna, Eduard Sarró, Thais Cuadros, Emilio Itarte, Maria Plana
Publikováno v:
Oncotarget
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Clear cell renal cell carcinoma (ccRCC) is the most common and aggressive subtype of renal cancer. STAT3 pathway is altered in these tumors and p-STAT3 Ser727 is an independent prognostic factor for ccRCC. Protein kinase CK2 is altered in different t
Autor:
Maria Plana, Lorenzo A. Pinna, Lucia Villamañan, Jordi Vilardell, Laura Ferrer-Font, Carles Arús, Ana Paula Candiota, Emilio Itarte, Nuria Arias-Ramos, Maria Ruzzene
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Pharmaceuticals
Pharmaceuticals; Volume 10; Issue 1; Pages: 24
Pharmaceuticals, Vol 10, Iss 1, p 24 (2017)
Universitat Autònoma de Barcelona
Pharmaceuticals
Pharmaceuticals; Volume 10; Issue 1; Pages: 24
Pharmaceuticals, Vol 10, Iss 1, p 24 (2017)
Glioblastoma (GBM) causes poor survival in patients even with aggressive treatment. Temozolomide (TMZ) is the standard chemotherapeutic choice for GBM treatment but resistance always ensues. Protein kinase CK2 (CK2) contributes to tumour development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efffe9daea5a891505c75a11a356f870
https://ddd.uab.cat/record/170144
https://ddd.uab.cat/record/170144